{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:28:05Z","timestamp":1777879685678,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.phymed.2026.158036","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:46:22Z","timestamp":1772610382000},"page":"158036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diosmetin alleviates the immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma by dually inhibiting angiogenesis and promoting CD8+T cell cytotoxicity"],"prefix":"10.1016","volume":"154","author":[{"given":"Xiaoxuan","family":"Duan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoshuo","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoya","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saijun","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziming","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangdong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9568-0031","authenticated-orcid":false,"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.phymed.2026.158036_bib0001","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1158\/0008-5472.CAN-22-1890","article-title":"Stromal reprogramming through dual PDGFRalpha\/beta blockade boosts the efficacy of Anti-PD-1 immunotherapy in fibrotic tumors","volume":"83","author":"Akiyama","year":"2023","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.phymed.2026.158036_bib0002","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/mol.117.110650","article-title":"Long noncoding RNA LINC00657 acting as a miR-590-3p sponge to facilitate low concentration oxidized low-density lipoprotein-induced angiogenesis","volume":"93","author":"Bao","year":"2018","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.phymed.2026.158036_bib0003","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","article-title":"Targeting angiogenesis in oncology, ophthalmology and beyond","volume":"22","author":"Cao","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2026.158036_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178008","article-title":"Diosmetin augments BRAF-targeted therapy via concurrent suppression of MAPK and STAT3 pathways in melanoma","volume":"1004","author":"Chen","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"29","key":"10.1016\/j.phymed.2026.158036_bib0005","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1038\/s41388-023-02750-2","article-title":"Diosmetin suppresses the progression of ESCC by CDK2\/Rb\/E2F2\/RRM2 pathway and synergies with cisplatin","volume":"42","author":"Chen","year":"2023","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.phymed.2026.158036_bib0006","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20250256","article-title":"Integrated screens identify AURKB dependency in advanced gastrointestinal stromal tumors","volume":"222","author":"Cheng","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phymed.2026.158036_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109525","article-title":"Endothelial cells-directed angiogenesis in colorectal cancer: interleukin as the mediator and pharmacological target","volume":"114","author":"Cui","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2026.158036_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216596","article-title":"Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3beta\/TCF7\/MMP9 pathway and synergies with capecitabine","volume":"582","author":"Dai","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2026.158036_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110736","article-title":"PHGDH promotes esophageal squamous cell carcinoma progression via Wnt\/beta-catenin pathway","volume":"109","author":"Duan","year":"2023","journal-title":"Cell Signal."},{"issue":"2","key":"10.1016\/j.phymed.2026.158036_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1681\/ASN.2018080853","article-title":"Therapeutic inhibition of VEGF signaling and associated nephrotoxicities","volume":"30","author":"Estrada","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0011","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41419-022-05539-5","article-title":"PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer","volume":"14","author":"Garlapati","year":"2023","journal-title":"Cell Death. Dis."},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0012","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.phymed.2026.158036_bib0013","article-title":"Endothelial cell in tumor angiogenesis: origins, mechanisms, and therapeutic implication","volume":"12","author":"Han","year":"2025","journal-title":"Genes. Dis."},{"issue":"3","key":"10.1016\/j.phymed.2026.158036_bib0014","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10456-023-09871-y","article-title":"Pathological angiogenesis: mechanisms and therapeutic strategies","volume":"26","author":"Hermans","year":"2023","journal-title":"Angiogenesis"},{"key":"10.1016\/j.phymed.2026.158036_bib0015","article-title":"Autoimmune encephalitis followed by hemophagocytic lymph histiocytosis: a case report","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2026.158036_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100849","article-title":"New insights into antiangiogenic therapy resistance in cancer: mechanisms and therapeutic aspects","volume":"64","author":"Huang","year":"2022","journal-title":"Drug Resist. Updat."},{"issue":"8","key":"10.1016\/j.phymed.2026.158036_bib0017","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-021-00496-y","article-title":"Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomes","volume":"18","author":"Huinen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0018","first-page":"25","article-title":"Rare immune-related adverse events (irAEs): approach to diagnosis and management","volume":"38","author":"Javaid","year":"2024","journal-title":"Pharmaceut. Med."},{"issue":"7","key":"10.1016\/j.phymed.2026.158036_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202204565","article-title":"Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in esophageal squamous cell carcinoma","volume":"10","author":"Jia","year":"2023","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.phymed.2026.158036_bib0020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ccell.2020.01.001","article-title":"Direct phosphorylation and stabilization of MYC by Aurora B kinase promote T-cell leukemogenesis","volume":"37","author":"Jiang","year":"2020","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.phymed.2026.158036_bib0021","doi-asserted-by":"crossref","first-page":"348","DOI":"10.21037\/jtd-22-856","article-title":"Global trends in the burden of esophageal cancer, 1990\u20132019: results from the Global Burden of Disease Study 2019","volume":"15","author":"Jiang","year":"2023","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0022","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41577-025-01211-z","article-title":"Linking tumour angiogenesis and tumour immunity","volume":"26","author":"Kabir","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-024-01364-2","article-title":"Trogocytosis-mediated immune evasion in the tumor microenvironment","volume":"57","author":"Kim","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"1\u20132","key":"10.1016\/j.phymed.2026.158036_bib0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41417-020-0191-x","article-title":"MicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinoma","volume":"28","author":"Li","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.phymed.2026.158036_bib0024","article-title":"Efficacy and safety of Lenvatinib Plus Everolimus in metastatic renal cell carcinoma after immune checkpoint and VEGFR tyrosine kinase inhibitors treatment","volume":"13","author":"Lee","year":"2025","journal-title":"Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.phymed.2026.158036_bib0026","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.amjms.2023.09.005","article-title":"Immunoregulation mechanism of VEGF signaling pathway inhibitors and its efficacy on the kidney","volume":"366","author":"Li","year":"2023","journal-title":"Am. J. Medical Sci."},{"issue":"11","key":"10.1016\/j.phymed.2026.158036_bib0027","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1080\/14740338.2024.2396387","article-title":"Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis","volume":"24","author":"Li","year":"2025","journal-title":"Expert. Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0028","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13046-025-03498-1","article-title":"Histone lactylation-boosted AURKB facilitates colorectal cancer progression by inhibiting HNRNPM-mediated PSAT1 mRNA degradation","volume":"44","author":"Li","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0029","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.phymed.2026.158036_bib0030","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0031","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12929-023-00912-8","article-title":"PES1 reduces CD8(+) T cell infiltration and immunotherapy sensitivity via interrupting ILF3-IL15 complex in esophageal squamous cell carcinoma","volume":"30","author":"Ma","year":"2023","journal-title":"J. Biomed. Sci."},{"issue":"3","key":"10.1016\/j.phymed.2026.158036_bib0032","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(21)00378-2","article-title":"Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial","volume":"7","author":"Meng","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2026.158036_bib0033","article-title":"Innovative approaches in immunomodulation for cell-based therapies","volume":"19","author":"Muhammad","year":"2025","journal-title":"Agrobiol. Rec."},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0034","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40659-021-00363-1","article-title":"Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3\/c-myc signaling pathway in human osteosarcoma cells","volume":"54","author":"Ning","year":"2021","journal-title":"Biol. Res."},{"issue":"2","key":"10.1016\/j.phymed.2026.158036_bib0036","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10456-022-09863-4","article-title":"Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy","volume":"26","author":"Nowak-Sliwinska","year":"2023","journal-title":"Angiogenesis"},{"issue":"11","key":"10.1016\/j.phymed.2026.158036_bib0037","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s10157-021-02090-z","article-title":"VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience","volume":"25","author":"Ozawa","year":"2021","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.phymed.2026.158036_bib0038","article-title":"PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway?","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158036_bib0039","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10456-017-9552-y","article-title":"Anti-angiogenesis for cancer revisited: is there a role for combinations with immunotherapy?","volume":"20","author":"Ramjiawan","year":"2017","journal-title":"Angiogenesis"},{"issue":"2","key":"10.1016\/j.phymed.2026.158036_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189079","article-title":"VEGF signaling: role in angiogenesis and beyond","volume":"1879","author":"Shaw","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0041","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"17","key":"10.1016\/j.phymed.2026.158036_bib0042","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2174\/0115680266355377250213054844","article-title":"Recent advances in diosmetin: pharmacological, pharmacokinetic, and toxicological profile","volume":"25","author":"Singh","year":"2025","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.phymed.2026.158036_bib63","first-page":"756","article-title":"Role and mechanisms of angiogenesis in tumours","volume":"14","author":"Sobczynska-Rak","year":"2025","journal-title":"Biology (Basel)"},{"issue":"21","key":"10.1016\/j.phymed.2026.158036_bib0043","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.3390\/cells11213470","article-title":"Visfatin-induced inhibition of miR-1264 facilitates PDGF-C synthesis in chondrosarcoma cells and enhances endothelial progenitor cell angiogenesis","volume":"11","author":"Song","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.phymed.2026.158036_bib0044","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"7649","key":"10.1016\/j.phymed.2026.158036_bib0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature21724","article-title":"Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming","volume":"544","author":"Tian","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phymed.2026.158036_bib0046","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1272\/jnms.JNMS.2022_89-221","article-title":"Current trends in anti-cancer molecular targeted therapies: renal complications and their histological features","volume":"89","author":"Tonooka","year":"2022","journal-title":"J. Nippon. Med. Sch."},{"key":"10.1016\/j.phymed.2026.158036_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1198972","article-title":"The application and research progress of anti-angiogenesis therapy in tumor immunotherapy","volume":"14","author":"Tu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2026.158036_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154862","article-title":"CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products","volume":"116","author":"Tu","year":"2023","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.phymed.2026.158036_bib0049","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/diagnostics11040640","article-title":"Nephrotoxicity of anti-angiogenic therapies","volume":"11","author":"Van Wynsberghe","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"10.1016\/j.phymed.2026.158036_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189155","article-title":"Targeting endothelial cell anergy to improve CAR T cell therapy for solid tumors","volume":"1879","author":"Wachholz","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0051","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10753-023-01911-5","article-title":"SIRT6 Protects against lipopolysaccharide-induced inflammation in Human pulmonary lung microvascular endothelial cells","volume":"47","author":"Wang","year":"2024","journal-title":"Inflammation"},{"key":"10.1016\/j.phymed.2026.158036_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111846","article-title":"Deciphering JAK\/STAT signaling pathway: a multifaceted approach to tumorigenesis, progression and therapeutic interventions","volume":"131","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0053","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/imm.13793","article-title":"Immunotherapy and the ovarian cancer microenvironment: exploring potential strategies for enhanced treatment efficacy","volume":"173","author":"Wang","year":"2024","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0054","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.phymed.2026.158036_bib0055","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/jcmm.17257","article-title":"Occludin facilitates tumour angiogenesis in bladder cancer by regulating IL8\/STAT3 through STAT4","volume":"26","author":"Yang","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.phymed.2026.158036_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113664","article-title":"Transdermal psoriasis treatment inspired by tumor microenvironment-mediated immunomodulation and advanced by exosomal engineering","volume":"382","author":"Yang","year":"2025","journal-title":"J. Control Release"},{"issue":"4","key":"10.1016\/j.phymed.2026.158036_bib0057","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70313","article-title":"Angiogenesis and targeted therapy in the tumour microenvironment: from basic to clinical practice","volume":"15","author":"Yang","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.phymed.2026.158036_bib0058","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1038\/s41467-024-52977-0","article-title":"Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.phymed.2026.158036_bib0059","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/s41388-021-01685-w","article-title":"Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis","volume":"40","author":"Yoon","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2026.158036_bib0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ebiom.2017.10.030","article-title":"Deguelin, an Aurora B kinase inhibitor, exhibits potent anti-tumor effect in Human esophageal squamous cell carcinoma","volume":"26","author":"Yu","year":"2017","journal-title":"EBioMedicine"},{"issue":"16","key":"10.1016\/j.phymed.2026.158036_bib0061","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3748\/wjg.v30.i16.2195","article-title":"Mechanisms of tumor immunosuppressive microenvironment formation in esophageal cancer","volume":"30","author":"Zhang","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phymed.2026.158036_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109753","article-title":"Aurora kinase B disruption suppresses pathological retinal angiogenesis by affecting cell cycle progression","volume":"239","author":"Zhu","year":"2024","journal-title":"Exp. Eye Res."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:50:46Z","timestamp":1777593046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326002722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":62,"alternative-id":["S0944711326002722"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158036","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diosmetin alleviates the immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma by dually inhibiting angiogenesis and promoting CD8+T cell cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158036"}}